{
    "id": 24042,
    "fullName": "PIK3R2 del",
    "impact": "deletion",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "PIK3R2 del indicates a deletion of the PIK3R2 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5296,
        "geneSymbol": "PIK3R2",
        "terms": [
            "PIK3R2",
            "MPPH",
            "MPPH1",
            "p85",
            "p85-BETA",
            "P85B"
        ]
    },
    "variant": "del",
    "createDate": "07/05/2016",
    "updateDate": "08/01/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7200,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY294002 inhibited growth of PIK3R2 null mouse B cells in culture (PMID: 18704194).",
            "molecularProfile": {
                "id": 24764,
                "profileName": "PIK3R2 del"
            },
            "therapy": {
                "id": 1062,
                "therapyName": "LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6195,
                    "pubMedId": 18704194,
                    "title": "Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18704194"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7199,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, mouse B cells null for both PIK3R1 and PIK3R2 demonstrated increased sensitivity to LY294002 in culture (PMID: 18704194).",
            "molecularProfile": {
                "id": 24765,
                "profileName": "PIK3R1 del PIK3R2 del"
            },
            "therapy": {
                "id": 1062,
                "therapyName": "LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6195,
                    "pubMedId": 18704194,
                    "title": "Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18704194"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24764,
            "profileName": "PIK3R2 del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24765,
            "profileName": "PIK3R1 del PIK3R2 del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}